Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
- PMID: 32016343
- PMCID: PMC7177478
- DOI: 10.1093/jac/dkaa004
Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
Abstract
Background: Staphylococcus lugdunensis belongs to the CoNS group, but is regarded to be more virulent than most other CoNS. It is also remarkably susceptible to antibiotics, including penicillin G.
Objectives: To evaluate different methods for penicillin susceptibility testing, to assess penicillin susceptibility rates among S. lugdunensis and to describe the clinical presentation including antibiotic treatment.
Methods: Clinical isolates of S. lugdunensis were tested for penicillin susceptibility using disc diffusion according to CLSI (10 U disc) and EUCAST (1 U disc), assessment of zone-edge appearance, nitrocefin test and Etest for MIC determination. PCR of the blaZ gene was used as a reference method.
Results: Of the 112 isolates included in the study, 67% were susceptible to penicillin G according to blaZ PCR. The EUCAST disc diffusion test had 100% sensitivity, whereas the CLSI method had one very major error with a false-susceptible isolate. When zone-edge appearance was included in the assessment, the false-susceptible isolate was correctly classified as resistant. Foreign-body infection was the most common focus of infection, affecting 49% of the participants. Only 4% of the patients were treated with penicillin G.
Conclusions: Penicillin susceptibility is common in S. lugdunensis and the disc diffusion method according to EUCAST had a higher sensitivity than that of CLSI. Assessment of zone-edge appearance could increase the sensitivity of the disc diffusion test. Penicillin susceptibility testing and treatment should be considered in S. lugdunensis infections.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Figures


Similar articles
-
Antimicrobial Susceptibility Testing for Staphylococcus lugdunensis.J Clin Microbiol. 2022 Jan 19;60(1):e0320220. doi: 10.1128/JCM.03202-20. Epub 2021 Oct 27. J Clin Microbiol. 2022. PMID: 34705537 Free PMC article.
-
Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.J Clin Microbiol. 2017 Feb;55(2):585-595. doi: 10.1128/JCM.02092-16. Epub 2016 Dec 7. J Clin Microbiol. 2017. PMID: 27927926 Free PMC article.
-
Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1449-1455. doi: 10.1007/s10096-019-03571-6. Epub 2019 May 29. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31144243 Free PMC article.
-
Clinical and microbiological characteristics of Staphylococcus lugdunensis.Curr Opin Infect Dis. 2022 Dec 1;35(6):524-529. doi: 10.1097/QCO.0000000000000882. Epub 2022 Oct 27. Curr Opin Infect Dis. 2022. PMID: 36305373 Review.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study.Eur J Clin Microbiol Infect Dis. 2021 May;40(5):1103-1106. doi: 10.1007/s10096-020-04134-w. Epub 2020 Dec 30. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33378000 Free PMC article.
-
Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management-Reanalysis of Retrospective Bacteremia Cohorts.Clin Infect Dis. 2024 Apr 10;78(4):956-963. doi: 10.1093/cid/ciae040. Clin Infect Dis. 2024. PMID: 38330240 Free PMC article.
-
Antimicrobial Susceptibility Testing for Staphylococcus lugdunensis.J Clin Microbiol. 2022 Jan 19;60(1):e0320220. doi: 10.1128/JCM.03202-20. Epub 2021 Oct 27. J Clin Microbiol. 2022. PMID: 34705537 Free PMC article.
References
-
- Ravaioli S, Selan L, Visai L. et al. Staphylococcus lugdunensis, an aggressive coagulase-negative pathogen not to be underestimated. Int J Artif Organs 2012; 35: 742–53. - PubMed
-
- Seng P, Traore M, Lavigne JP. et al. Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices. Int Orthop 2017; 41: 1085–91. - PubMed
-
- Lourtet-Hascoet J, Bicart-See A, Felice MP. et al. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis. Int J Infect Dis 2016; 51: 56–61. - PubMed
-
- Argemi X, Prevost G, Riegel P. et al. VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. Clin Microbiol Infect 2017; 23: 334.e1–8. - PubMed